SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is currently seeing volatile trading as investors weigh concerns over Medicare Advantage reimbursement rates and regulatory pressures against the company's long-term potential as a defensive sector leader. The community is actively debating whether current price levels represent a significant buying opportunity ahead of upcoming policy decisions, with many participants closely monitoring institutional positioning and sector-wide sentiment.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is experiencing significant market volatility and high trading volume as investors react to a transformational earnings report featuring robust revenue guidance and the integration of its recent acquisition. The community is actively debating the timing of potential major contract awards, with bullish sentiment driven by the company's ambitious 2026 outlook and its unique position in lunar infrastructure, while short sellers remain focused on execution risks and past delays.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is experiencing significant volatility and aggressive upside momentum as retail traders speculate on its high-profile private equity holdings like Anthropic, OpenAI, and SpaceX. While the community is debating the stock's massive premium over its net asset value and the impact of a six-month lockup period on the majority of existing shares, many are actively monitoring technical chart patterns and volume spikes to identify entry and exit points for what they perceive as a high-risk, high-reward trading opportunity.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings shares are facing volatility as the market reacts to intense competition from prediction markets like Kalshi and Polymarket, which are currently fueling debate over regulatory oversight and their long-term impact on traditional sportsbook revenue. While DraftKings is leaning into its own 'Super App' strategy to capture market share and enhance margins, community sentiment remains split between investors betting on a sports-betting rebound and those concerned by persistent insider selling and the broader threat to the existing legislative moat.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

The SPERMWHALE token is sparking polarized debate as traders contrast its resilience against broader market volatility with concerns regarding its speculative nature. Community sentiment remains split between those observing quiet accumulation patterns and those skeptical of its long-term viability.

The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. It sells products under Estée Lauder, Clinique, Origins, MAC, Bobbi Brown, La Mer, Jo Malone London, Aveda and Too Faced. The company was founded by Estee Lauder and Joseph Lauder in 1946 and is headquartered in New York, NY.

Estee Lauder Cos., Inc. - Ordinary Shares - Class A

Estee Lauder Cos. Inc

Este Lauder is trending following reports that it is nearing a merger deal with Puig, the parent company of Jean Paul Gaultier, sparking intense community debate over the potential impact on shareholder value. While some investors view the deal as a significant turnaround catalyst, others are actively questioning whether the merger will leave existing shareholders with diluted equity or meaningful long-term upside.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is rallying as shareholders celebrate a major leadership overhaul, including the appointment of Kevin Tang as CEO, which the community views as a critical step toward fiscal discipline and a potential sale of the company. Investors are actively discussing the removal of the previous CEO and the new leadership's decision to forgo traditional compensation, signaling to the market that the company is now positioning itself to maximize shareholder value.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is facing intense volatility as investors debate the impact of major insider share sales by leadership alongside the ongoing market anticipation for a potential strategic partnership or asset deal with POSCO. While some retail traders are aggressively buying the dip, citing strong forward demand and undervalued asset potential, others are concerned about the company's debt levels and a lack of clear catalysts to break the current downward trend.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is currently trending due to its aggressive global expansion, highlighted by live driverless robotaxi operations with Uber in the Middle East and new partnerships with Grab in Singapore. While the community is actively debating the company's long-term valuation and future revenue potential, investor sentiment remains mixed as they wait for more transparency from leadership regarding the 2026 growth roadmap.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is experiencing extreme volatility and selling pressure following recent earnings, with the community actively debating whether the price action reflects a disconnect between strong fundamentals and market optics or a broader biotech sector sell-off. Investors are divided, with many expressing deep frustration over the lack of aggressive share buybacks and communication from leadership, while others see the current dip as a strategic accumulation opportunity given the company's long-term growth trajectory and potential for future M&A activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Marvell Technology Deepens Its Connectivity Portfolio: What's Ahead?

MRVL boosts its connectivity portfolio with new AI-driven solutions, strong data center growth and ambitious interconnect forecasts despite rising competition.

CRDO vs. MRVL: Which AI Connectivity Stock Is the Better Buy?

AI data center boom lifts both Credo and Marvell, but divergent growth rates, valuations and strategies reveal distinct risk-reward profiles for investors.

Infrastructure Stocks To Add to Your Watchlist - March 22nd

Vertiv, International Business Machines, Coinbase Global, Marvell Technology, Cheniere Energy, Alibaba Group, and Welltower are the seven Infrastructure stocks to watch today, according to MarketBeat's stock screener tool. Infrastructure stocks are shares of companies that build, own, or operate th...

Nordea Investment Management AB Sells 2,363,066 Shares of Marvell Technology, Inc. $MRVL

Nordea Investment Management AB trimmed its holdings in shares of Marvell Technology, Inc. (NASDAQ:MRVL - Free Report) by 40.0% during the 4th quarter, according to the company in its most recent...

Hudson Bay Capital Management LP Cuts Stake in Marvell Technology, Inc. $MRVL

Hudson Bay Capital Management LP lessened its stake in Marvell Technology, Inc. (NASDAQ:MRVL - Free Report) by 62.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,263 shares of the semiconductor compan...

Better Semiconductor Stock: Broadcom vs. Marvell Technology

Key PointsBoth Marvell and Broadcom are leaders in ASIC technology...

Infrastructure Stocks To Research - March 21st

Vertiv, International Business Machines, Coinbase Global, Marvell Technology, and Cheniere Energy are the five Infrastructure stocks to watch today, according to MarketBeat's stock screener tool...

MassMutual Private Wealth & Trust FSB Sells 17,915 Shares of Marvell Technology, Inc. $MRVL

MassMutual Private Wealth & Trust FSB lowered its holdings in shares of Marvell Technology, Inc. (NASDAQ:MRVL - Free Report) by 20.8% in the 4th quarter, according to its most recent disclosure with...

Swiss Life Asset Management Ltd Grows Stock Position in Marvell Technology, Inc. $MRVL

Swiss Life Asset Management Ltd increased its stake in Marvell Technology, Inc. (NASDAQ:MRVL - Free Report) by 16.3% in the third quarter, according to the company in its most recent Form 13F filing...

Marvell Technology (NASDAQ:MRVL) Stock Price Down 1.8%  - Here's What Happened

Marvell Technology (NASDAQ:MRVL) Shares Down 1.8% - Here's Why...

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Current Price	$90.16
Prev Close	$87.91
Open	$89.36
Dividend Yield	0.30%
50-Day Moving Average	$82.20
Beta	2.44
Avg. Volume	13.21M
PE Ratio	28.44

52-Week High	$102.77
52-Week Low	$47.09
Market Capitalization	$76.86B
EPS (Annual)	$3.07
Price to Book	5.21
Revenue Per Employee	$1.1M

MRVL
Marvell Technology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MRVL News

MRVLMarvell Technology Inc